A high-plex PCR approach for massively parallel sequencing

BioTechniques

Volumn 55, Issue 2, 2013, Pages 69-74

  Nguyen Dumont, Tú ^a   Pope, Bernard J ^a   Hammet, Fleur ^a   Southey, Melissa C ^a   Park, Daniel J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Disease gene screening; FFPE tissue; Hi Plex; High plex PCR; Massively parallel sequencing; Molecular diagnostics; Sequence screening

Indexed keywords

PRIMER DNA; DNA; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PALB2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; XRCC2 PROTEIN, HUMAN;

AMPLICON; ARTICLE; BREAST CANCER; GEL ELECTROPHORESIS; GENE SEQUENCE; HIGH THROUGHPUT SCREENING; MICROARRAY ANALYSIS; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; CHEMISTRY; DNA SEQUENCE; ECONOMICS; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; PROCEDURES; TIME; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA PRIMERS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEAR PROTEINS; SEQUENCE ANALYSIS, DNA; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84881499744     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000114052     Document Type: Article

References (26)

1. Mardis, E.R. 2008. The impact of next-generat ion sequencing technology on genetics. Trends Genet. 24:133-141.
2. Shendure, J. and H. Ji. 2008. Next-generation DNA sequencing. Nat. Biotechnol. 26:1135-1145.
3. Tavtigian, S.V., P.J. Oefner, D. Babikyan, A. Hartmann, S. Healey, F. Le Calvez-Kelm, F. Lesueur, G.B. Byrnes, et al. 2009. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am. J. Hum. Genet. 85:427-446.
4. Le Calvez-Kelm, F., F. Lesueur, F. Damiola, M. Vallee, C. Voegele, D. Babikyan, G. Durand, N. Forey, et al. 2011. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Res. 13:R6.
5. Morgan, J.E., I.M. Carr, E. Sheridan, C.E. Chu, B. Hayward, N. Camm, H.A. Lindsay, C.J. Mattocks, et al. 2010. Genetic diagnosis of familial breast cancer using clonal sequencing. Hum. Mutat. 31:484-491.
6. Meldrum, C., M.A. Doyle, and R.W. Tothill. 2011. Next-generation sequencing for cancer diagnostics: a practical perspective. Clin. Biochem. Rev. 32:177-195.
7. Moorthie, S., C.J. Mattocks, and C.F. Wright. 2011. Review of massively parallel DNA sequencing technologies. The HUGO journal 5:1-12.
8. Mamanova, L., A.J. Coffey, C.E. Scott, I. Kozarewa, E.H. Turner, A. Kumar, E. Howard, J. Shendure, and D.J. Turner. 2010. Target-enrichment strategies for next-generation sequencing. Nat. Methods 7:111-118.
9. Yang, M.M., A. Singhal, S.R. Rassekh, S. Yip, P. Eydoux, and C. Dunham. 2012. Possible differentiation of cerebral glioblastoma into pleomorphic xanthoastrocytoma: an unusual case in an infant. Journal of neurosurgery. Pediatrics 9:517-523.
10. Schulz, E., A. Valentin, P. Ulz, C. Beham-Schmid, K. Lind, V. Rupp, H. Lackner, A. Wolfler, et al. 2012. Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. J. Med. Genet. 49:422-428.
11. Tewhey, R., J.B. Warner, M. Nakano, B. Libby, M. Medkova, P.H. David, S.K. Kotsopoulos, M.L. Samuels, et al. 2009. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat. Biotechnol. 27:1025-1031.
12. Schweiger, M.R., M. Kerick, B. Timmermann, M.W. Albrecht, T. Borodina, D. Parkhomchuk, K. Zatloukal, and H. Lehrach. 2009. Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS ONE 4:e5548.
13. Rahman, N., S. Seal, D. Thompson, P. Kelly, A. Renwick, A. Elliott, S. Reid, K. Spanova, et al. 2007. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39:165-167.
14. Southey, M.C., Z.L. Teo, J.G. Dowty, F.A. Odefrey, D.J. Park, M. Tischkowitz, N. Sabbaghian, C. Apicella, et al. 2010. A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res. 12:R109.
15. Park, D.J., F. Lesueur, T. Nguyen-Dumont, M. Pertesi, F. Odefrey, F. Hammet, S.L. Neuhausen, E.M. John, et al. 2012. Rare mutations in XRCC2 increase the risk of breast cancer. Am. J. Hum. Genet. 90:734-739.
16. Hopper, J.L., G. Chenevix-Trench, D.J. Jolley, G.S. Dite, M.A. Jenkins, D.J. Venter, M.R. McCredie, and G.G. Giles. 1999. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J. Natl. Cancer Inst. Monogr. 25:95-100.
17. Rose, T.M., J.G. Henikoff, and S. Henikoff. 2003. CODEHOP (COnsensus-DEgenerate Hybrid Oligonucleotide Primer) PCR primer design. Nucleic Acids Res. 31:3763-3766.
18. Wong, M.L. and J.F. Medrano. 2005. Real-time PCR for mRNA quantitation. BioTechniques 39:75-85.
19. Yuan, J.S., A. Reed, F. Chen, and C.N. Stewart, Jr. 2006. Statistical analysis of real-time PCR data. BMC Bioinformatics 7:85.
20. Su, X.Z., Y. Wu, C.D. Sifri, and T.E. Wellems. 1996. Reduced extension temperatures required for PCR amplification of extremely A+T-rich DNA. Nucleic Acids Res. 24:1574-1575.
21. Aird, D., M.G. Ross, W.S. Chen, M. Danielsson, T. Fennell, C. Russ, D.B. Jaffe, C. Nusbaum, and A. Gnirke. 2011. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 12:R18.
22. Quail, M.A., M. Smith, P. Coupland, T.D. Otto, S.R. Harris, T.R. Connor, A. Bertoni, H.P. Swerdlow, and Y. Gu. 2012. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacif ic Biosciences and Illumina MiSeq sequencers. BMC Genomics 13:341.
23. Kibbe, W.A. 2007. OligoCalc: an online ol igonucleot ide properties calculator. Nucleic Acids Res. 35:W43-W46.
24. Holleley, C.E. and P.G. Geerts. 2009. Multiplex Manager 1.0: a cross-platform computer program that plans and optimizes multiplex PCR. BioTechniques 46:511-517.
25. Shen, Z., W. Qu, W. Wang, Y. Lu, Y. Wu, Z. Li, X. Hang, X. Wang, et al. 2010. MPprimer: a program for reliable multiplex PCR primer design. BMC Bioinformatics 11:143.
26. Souvenir, R., J. Buhler, G. Stormo, and W. Zhang. 2007. An iterative method for selecting degenerate multiplex PCR primers. Methods Mol. Biol. 402:245-268.